Related Experiment Video
Updated: Jul 15, 2026
06:45
Affinity Purification of a Fibrinolytic Enzyme from Sipunculus nudus
Published on: June 2, 2023
[Plasminogen activator from Agkistrodon halys halys venom]
Ukrains'Kyi Biokhimichnyi Zhurnal (1999 )
|May 15, 2007
Summary
A novel plasminogen activator, Ahh-32, was purified from snake venom. This enzyme converts plasminogen to plasmin and may aid in studying blood clotting mechanisms.
Area of Science:
- Biochemistry
- Venom research
- Hemostasis
Background:
- Snake venom contains various enzymes with biological activity.
- Plasminogen activators play a crucial role in the fibrinolytic system.
- Understanding novel activators can provide insights into hemostasis.
Purpose of the Study:
- To isolate and characterize a novel plasminogen activator from Agkistrodon halys halys venom.
- To investigate the enzymatic properties and interactions of the purified activator.
- To explore its potential applications in biochemical research.
Main Methods:
- Affinity and ion-exchange chromatography for enzyme purification.
- Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for molecular weight determination.
- Enzyme activity assays to assess plasminogen activation and inhibition.
Main Results:
- Isolation and purification of a single-chain protein, Ahh-32, with a molecular weight of 32 kDa.
- Demonstration of Ahh-32's ability to convert plasminogen to plasmin.
- Inhibition of Ahh-32 by DFP and benzamidine.
- Differential effect on plasminogen activation by streptokinase versus tissue plasminogen activator.
Conclusions:
- Ahh-32 is a novel plasminogen activator from Agkistrodon halys halys venom.
- The enzyme exhibits specific inhibitory characteristics.
- Ahh-32 can modulate plasminogen activation pathways, offering a tool for hemostasis research.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:16Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
01:26Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...